SCHEMBL6677359

SCHEMBL6677359

COC(=O)c1cc(S(=O)(=O)c2ccc(C[C@@H](C)NC(=O)C(F)(F)F)cc2)c(OC)cc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.45
ABCC9 O60706 2/20 0.39
ABCC8 Q09428 2/20 0.39
KCNJ11 Q14654 2/20 0.39
KCNJ8 Q15842 2/20 0.39
ACACB O00763 8/20 0.38
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
KMT2A Q03164 1/20 0.35
ESR1 P03372 1/20 0.35
KCNH2 Q12809 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
GAA P10253 1/20 0.35
ALOX15 P16050 1/20 0.35
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6805535 0.89 CNR1 (0.43) CNR1ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL6805794 0.86 MAPT (0.42) CNR1ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL6809238 0.82 CNR1 (0.46) CNR1ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL6681814 0.82 CNR1 (0.48) CNR1ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL6540840 0.81 NAMPT (0.45) CNR1ACACBKMT2A
SCHEMBL6680778 0.79 CNR1 (0.40) CNR1ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL6541239 0.79 CNR1 (0.44) CNR1ACACBALDH1A1ESR1KCNH2
SCHEMBL6806001 0.78 ACACB (0.45) CNR1ACACBALDH1A1KMT2ACYP3A4
SCHEMBL6540590 0.78 ACACB (0.45) CNR1ACACBALDH1A1KMT2ACYP3A4
SCHEMBL6541208 0.78 CNR1 (0.56) CNR1ACACBALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed
WO-2004045610-A1 AMINOALCOHOL DERIVATIVES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS FUJISAWA PHARMACEUTICAL CO., LTD (JP) 2004-06-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 CNR1 112/4885ABCC9 1596/4885ABCC8 997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.